STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a pacesetter in Polymerase Chain Reaction (PCR)-based DNA manufacturing, at present introduced the enlargement of business actions below its multi-year Master Services Agreement (MSA) with Vitamin21 whereby Vitamin21 has transitioned to Applied DNA’s CertainT® platform to safe its IP-protected portfolio of dietary complement components. Concurrently, the Company obtained two follow-on orders for a second yr of business manufacturing, the bulk of which is predicted to be shipped within the present fiscal quarter. The monetary phrases of the follow-on orders weren’t disclosed.
Vitamin21, a trusted developer and provider of novel and clinically substantiated branded components for the dietary complement trade, is the primary to undertake the platform to defend the IP of its components. Utilizing CertainT, Vitamin21 can certify that its licensees use genuine components and within the correct quantities, and in addition determine IP infringement by non-licensees. A SigNature® molecular tag is utilized to Vitamin21 components to present proof of its product dosages in completed merchandise shipped to market. The molecular tag is supported by ongoing high quality management testing providers for manufacturing and high-resolution testing providers for merchandise audited in-market. Vitamin21 holds over 100 home and worldwide issued and pending patents for its merchandise.
“The expansion of CertainT’s application within Nutrition21 is testament to our platform’s ability to support Nutrition21’s dedication to ensuring confidence in its ingredients portfolio,” mentioned Dr. James A. Hayward, president and CEO, Applied DNA. “With its diverse portfolio of patented health and wellness ingredients, we believe we are in the early stages of an impactful commercial relationship with Nutrition21 and, by proxy, the dietary supplements industry.”
Joe Weiss, President of Vitamin21, acknowledged, “After an extensive search to replace our current marker technology, we have now transitioned to the CertainT platform. Marketing partners and customers of Nutrition21 can rest assured that we will utilize the CertainT platform to protect them against infringers of our intellectual property, and most importantly, assure consumers that they are getting the Nutrition21 ingredients that are listed on their product label.”
The CertainT® platform has three know-how pillars (Tag, Test, Track), which permits uncooked supplies and merchandise to be tagged with a novel molecular identifier. This identifier can then be examined for its presence because it travels all through a worldwide provide chain. All the information factors related to tagging and testing are tracked by importing to a safe cloud database. The platform can be utilized throughout industries equivalent to textiles, hashish, navy, leather-based, fertilizer, prescribed drugs, private care.
About Vitamin21, LLC
Vitamin21 is a trusted developer and provider of novel and clinically substantiated branded components for the dietary complement trade. With a various portfolio of patented well being and wellness components, Vitamin21 offers ingredient options to some of probably the most profitable dietary complement manufacturers within the market at present.
Vitamin21 at present holds over 100 home and worldwide issued and pending patents for merchandise with extremely marketable claims together with: Nitrosigine®, Velositol®, Chromax®, nooLVL®, and Lepidamax®. Innovative Ingredients. Real Results
For extra info, please go to: www.Nutrition21.com.
About Applied DNA Sciences
Applied DNA is a supplier of molecular applied sciences that allow provide chain safety, anti-counterfeiting and anti-theft know-how, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.
The Company’s frequent inventory is listed on NASDAQ below ticker image ‘APDN’, and its publicly traded warrants are listed on OTC below ticker image ‘APPDW’.
Applied DNA is a member of the Russell Microcap® Index.
The statements made by Applied DNA on this press launch could also be “forward-looking” in nature throughout the which means of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, methods and expectations, and are primarily based on assumptions and contain a quantity of dangers and uncertainties, many of that are past the management of Applied DNA. Actual outcomes might differ materially from these projected due to, its historical past of internet losses, restricted monetary sources, restricted market acceptance, the uncertainties inherent in analysis and improvement, our capacity to efficiently enter into business contracts for the implementation of our CertainT® platform, disruptions within the provide of uncooked supplies and provides, and numerous different elements detailed from time to time in Applied DNA’s SEC experiences and filings, together with our Annual Report on Form 10-Ok filed on December 12, 2019 and our subsequent quarterly experiences on Form 10-Q filed on February 6, 2020, May 14, 2020 and August 6, 2020, and different experiences we file with the SEC, which can be found at www.sec.gov. Applied DNA undertakes no obligation to replace publicly any forward-looking statements to replicate new info, occasions or circumstances after the date hereof or to replicate the prevalence of unanticipated occasions, except in any other case required by regulation.